宫颈癌淋巴结的评估与手术策略探讨

doi:10.12114/j.issn.1007-9572.2021.02.111

中国全科医学 ›› 2022, Vol. 25 ›› Issue (18): 2235-2238.DOI: 10.12114/j.issn.1007-9572.2021.02.111

所属专题：肿瘤最新文章合集

• 论著·宫颈癌专题研究 • 上一篇下一篇

宫颈癌淋巴结的评估与手术策略探讨

张清泉, 王世军^*()

100053　北京市，首都医科大学宣武医院妇产科

收稿日期:2021-08-12 修回日期:2021-11-12 出版日期:2022-06-20 发布日期:2021-11-18
通讯作者: 王世军
张清泉，王世军.宫颈癌淋巴结的评估与手术策略探讨[J].中国全科医学，2022，25（18）：2235-2238. [www.chinagp.net]
作者贡献：张清泉负责文章的构思与设计，以及文章撰写；王世军负责研究的实施与可行性分析、论文修订、文章的质量控制及审校，并且对文章整体负责、监督管理。

Assessment and Surgical Strategies for Lymphatic Metastasis in Cervical Cancer

Qingquan ZHANG, Shijun WANG^*()

Department of Gynaecology and Obstetrics, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

Received:2021-08-12 Revised:2021-11-12 Published:2022-06-20 Online:2021-11-18
Contact: Shijun WANG
About author:
ZHANG Q Q, WANG S J. Assessment and surgical strategies for lymphatic metastasis in cervical cancer[J]. Chinese General Practice, 2022, 25 (18) : 2235-2238.

分享到

摘要/Abstract

摘要： 宫颈癌是妇科常见的恶性肿瘤之一。手术治疗是早期宫颈癌的重要治疗方式。宫颈癌患者是否存在淋巴结转移对评估宫颈癌预后及治疗方案的选择具有重要的意义，而术前根据淋巴结转移的相关危险因素及影像学检查结果评估淋巴结转移的情况，有助于临床制订手术策略。近年来，前哨淋巴结活检术因其安全性及可行性已被推荐应用于早期宫颈癌患者的手术治疗，可根据宫颈癌患者术前淋巴结评估情况选择性地进行前哨淋巴结活检、系统性淋巴结切除及腹主动脉旁淋巴结切除，根据术中淋巴结转移情况可制订相应的手术切除范围。因此，宫颈癌淋巴结的评估尤其是手术策略的制订在宫颈癌治疗中具有重要的意义。

关键词: 宫颈肿瘤, 淋巴结评估, 前哨淋巴结, 前哨淋巴结活组织检查, 手术策略

Abstract:

Cervical cancer is a common gynecologic malignant tumor. Surgical treatment is an important treatment for early stage cervical cancer. Whether having lymph node metastasis is of great significance to the assessment of the prognosis of cervical cancer and the choice of treatment options. Preoperative assessment of lymph node metastasis based on identified related risk factors and imaging findings is helpful to the formulation of surgical strategies. In recent years, sentinel lymph node biopsy has been recommended for surgical treatment of patients with early stage cervical cancer due to its safety and feasibility. Patients with cervical cancer can selectively undergo sentinel lymph node biopsy, systematic lymph node resection, or para-aortic lymph node resection based on their preoperative lymph node assessment. According to intraoperative diagnosis of the degree of lymph node involvement, the extent of surgical resection can be determined. So the assessment of lymphatic metastasis, especially the formulation of surgical strategieswere of great significance in the treatment of cervical cancer.

Key words: Uterine cervical neoplasms, Lymph node assessment, Sentinel lymph node, Sentinel lymph node biopsy, Surgical strategy

张清泉,王世军. 宫颈癌淋巴结的评估与手术策略探讨[J]. 中国全科医学, 2022, 25(18): 2235-2238. DOI: 10.12114/j.issn.1007-9572.2021.02.111.
Qingquan ZHANG,Shijun WANG. Assessment and Surgical Strategies for Lymphatic Metastasis in Cervical Cancer[J]. Chinese General Practice, 2022, 25(18): 2235-2238. DOI: 10.12114/j.issn.1007-9572.2021.02.111.

参考文献 30

[1]	BRAY F, FERLAY J, SOERJOMATARAM I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin，2018，68(6):394-424. DOI：10.3322/caac.21492.
[2]	CHEN B X, WANG L M, REN C，et al. The effect of neoadjuvant chemotherapy on lymph node metastasis of FIGO stage ⅠB1-ⅡB cervical cancer：a systematic review and meta-analysis[J]. Front Oncol，2020，10:570258. DOI：10.3389/fonc.2020.570258.
[3]	WIDSCHWENDTER P, JANNI W, SCHOLZ C，et al. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer[J]. Arch Gynecol Obstet，2019，300(6):1709-1718. DOI：10.1007/s00404-019-05341-3.
[4]	BUJNAK A C, TEWARI K S. Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?[J]. J Gynecol Oncol，2021，32(4):e62. DOI：10.3802/jgo.2021.32.e62.
[5]	KILIC C, KIMYON COMERT G, CAKIR C，et al. Recurrence pattern and prognostic factors for survival in cervical cancer with lymph node metastasis[J]. J Obstet Gynaecol Res，2021，47(6):2175-2184. DOI：10.1111/jog.14762.
[6]	ZHAO W C, YANG Q. Lymph-vascular space invasion in patients with stages IA2-IIA2 cervical cancer treated with laparoscopic versus open radical hysterectomy[J]. Cancer Manag Res，2021，13:1179-1186. DOI：10.2147/CMAR.S292477.
[7]	MCCOMAS K N, TORGESON A M, AGER B J，et al. The variable impact of positive lymph nodes in cervical cancer：implications of the new FIGO staging system[J]. Gynecol Oncol，2020，156(1):85-92. DOI：10.1016/j.ygyno.2019.10.025.
[8]	贾鹏欢，刘晓云，宋小磊，等. 在体女性盆腔淋巴结数字化三维模型构建及测量[J]. 中国数字医学，2021，16(5):91-96. DOI：10.3969/j.issn.1673-7571.2021.05.020.
[9]	胡郅珺，刘开江，刘青，等. PET/CT对早期宫颈癌后腹膜淋巴结转移的诊断价值[J]. 中国医师杂志，2021，23(2):193-197,202. DOI：10.3760/cma.j.cn431274-20210118-00069.
[10]	崔雅琼，王莉莉，赵莲萍，等. 宫颈癌影像组学研究进展[J]. 磁共振成像，2020，11(6):477-480. DOI：10.12015/issn.1674-8034.2020.06.020.
[11]	XIAO M, MA F, LI Y，et al. Multiparametric MRI-based radiomics nomogram for predicting lymph node metastasis in early-stage cervical cancer[J]. J Magn Reson Imaging，2020，52(3):885-896. DOI：10.1002/jmri.27101.
[12]	林蓓，凌斌，张师前，等. 妇科恶性肿瘤盆腔淋巴结切除术后淋巴囊肿诊治专家共识（2020年版）[J]. 中国实用妇科与产科杂志，2020，36(10):959-964. DOI：10.19538/j.fk2020100113.
[13]	中国妇幼保健协会妇科肿瘤防治专业委员会. 妇科肿瘤治疗后下肢淋巴水肿专家共识[J]. 中国临床医生杂志，2021，49(2):149-155. DOI：10.3969/j.issn.2095-8552.2021.02.006.
[14]	CAPOZZI V A, SOZZI G, MONFARDINI L，et al. Transperitoneal versus extraperitoneal laparoscopic aortic lymph nodal staging for locally advanced cervical cancer：a systematic review and meta-analysis[J]. Eur J Surg Oncol，2021，47(9):2256-2264. DOI：10.1016/j.ejso.2021.04.036.
[15]	周晖，刘昀昀，罗铭，等. 《2021 NCCN子宫颈癌临床实践指南（第1版）》解读[J]. 中国实用妇科与产科杂志，2020，36(11):1098-1104. DOI：10.19538/j.fk2020110115.
[16]	FERRANDINA G, PEDONE ANCHORA L, GALLOTTA V，et al. Can we define the risk of lymph node metastasis in early-stage cervical cancer patients? A large-scale，retrospective study[J]. Ann Surg Oncol，2017，24(8):2311-2318. DOI：10.1245/s10434-017-5917-0.
[17]	MATHEVET P, LÉCURU F, UZAN C，et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer：Results of a multicentre randomised trial （SENTICOL-2）[J]. Eur J Cancer，2021，148:307-315. DOI：10.1016/j.ejca.2021.02.009.
[18]	FAVRE G, GUANI B, BALAYA V，et al. Sentinel lymph-node biopsy in early-stage cervical cancer：the 4-year follow-up results of the senticol 2 trial[J]. Front Oncol，2020，10:621518. DOI：10.3389/fonc.2020.621518.
[19]	ROB L, LUKAS R, ROBOVA H，et al. Current status of sentinel lymph node mapping in the management of cervical cancer[J]. Expert Rev Anticancer Ther，2013，13(7):861-870. DOI：10.1586/14737140.2013.811147.
[20]	CIBULA D, BORCINOVÁ M, MARNITZ S，et al. Lower-limb lymphedema after sentinel lymph node biopsy in cervical cancer patients[J]. Cancers （Basel），2021，13(10):2360. DOI：10.3390/cancers13102360.
[21]	YA X, QIAN W, HUIQING L，et al. Role of carbon nanoparticle suspension in sentinel lymph node biopsy for early-stage cervical cancer：a prospective study[J]. BJOG，2021，128(5):890-898. DOI：10.1111/1471-0528.16504.
[22]	BIZZARRI N, LUIGI P A, FERRANDINA G，et al. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy：a single-institution series[J]. J Cancer Res Clin Oncol，2021，147(3):649-659. DOI：10.1007/s00432-020-03393-6.
[23]	ZHANG X Y, BAO B T, WANG S X，et al. Sentinel lymph node biopsy in early stage cervical cancer：a meta-analysis[J]. Cancer Med，2021，10(8):2590-2600. DOI：10.1002/cam4.3645.
[24]	白璐，李雯慧，陈必良. 宫颈癌新辅助化疗的现状与争议[J]. 现代肿瘤医学，2019，27(7):1278-1280. DOI：10.3969/j.issn.1672-499.2019.07.046.
[25]	SMITS R M, ZUSTERZEEL P L, BEKKERS R L. Pretreatment retroperitoneal Para-aortic lymph node staging in advanced cervical cancer：a review[J]. Int J Gynecol Cancer，2014，24(6):973-983. DOI：10.1097/IGC.0000000000000177.
[26]	LIU J P, LIU X, GUO Z Y，et al. Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer：diagnostic accuracy and impact on clinical decision making[J]. BMC Cancer，2021，21(1):964. DOI：10.1186/s12885-021-08492-2.
[27]	YANG J, DELARA R, MAGRINA J，et al. Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer：a propensity score-matched analysis[J]. Gynecol Oncol，2020，156(2):320-327. DOI：10.1016/j.ygyno.2019.12.009.
[28]	MARTINEZ A, ANGELES M A, QUERLEU D，et al. How should we stage and tailor treatment strategy in locally advanced cervical cancer? Imaging versus Para-aortic surgical staging[J]. Int J Gynecol Cancer，2020，30(9):1434-1443. DOI：10.1136/ijgc-2020-001351.
[29]	陆安伟，周莉. 子宫颈癌C1型术式的规范化[J]. 中国实用妇科与产科杂志，2021，37(1):48-51. DOI：10.19538/j.fk2021010112.
[30]	CIBULA D, DOSTALEK L, HILLEMANNS P，et al. Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement：ABRAX international retrospective cohort study[J]. Eur J Cancer，2021，143:88-100. DOI：10.1016/j.ejca.2020.10.037.

宫颈癌淋巴结的评估与手术策略探讨

Assessment and Surgical Strategies for Lymphatic Metastasis in Cervical Cancer

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 15

编辑推荐

Metrics

留言

[1]	夏依旦·罗合曼江, 杜蓉. 不同级别宫颈病变与人乳头瘤病毒感染及阴道微环境的关系研究[J]. 中国全科医学, 2022, 25(23): 2881-2884.
[2]	刘双环, 李斌. 宫颈癌根治性手术的术式精准选择与实施[J]. 中国全科医学, 2022, 25(18): 2231-2234.
[3]	林雨璇, 孔为民, 王元景, 李凤霜. 放射治疗在宫颈癌治疗中的应用及更新[J]. 中国全科医学, 2022, 25(18): 2239-2243.
[4]	刘玉, 韦艳, 杨萍. 2019年和2020年新疆石河子城区宫颈癌筛查结果对比研究[J]. 中国全科医学, 2022, 25(18): 2223-2230.
[5]	王瑾瑶, 张年萍, 白志强, 王震坤. 1993—2017年中国宫颈癌发病率和死亡率长期趋势的年龄-时期-队列模型分析[J]. 中国全科医学, 2022, 25(13): 1564-1568.
[6]	徐碧霞, 林小丹, 姚卫光. 2015—2019年广东省户籍妇女宫颈癌患病率时间和空间分布特征分析[J]. 中国全科医学, 2022, 25(06): 735-741.
[7]	张军. 宫颈癌治疗的现状及问题：从临床指南到真实世界研究[J]. 中国全科医学, 2022, 25(03): 259-263.
[8]	李婷婷，王翠峰. 高危型人乳头瘤病毒联合宫颈液基薄层细胞学检测在宫颈上皮内瘤变筛查中的应用价值[J]. 中国全科医学, 2021, 24(9): 1106-1110.
[9]	韦艳，白瑞，阮阳阳，孙倩玉，刁博文，杨萍. 新疆维吾尔自治区石河子市城区18 378例子宫颈癌筛查人群的hrHPV感染状况研究[J]. 中国全科医学, 2021, 24(29): 3763-3768.
[10]	中国医师协会全科医师分会，北京妇产学会社区与基层分会. 子宫颈癌筛查结果异常人群社区管理专家建议[J]. 中国全科医学, 2021, 24(17): 2117-2121.
[11]	张涛红，张萌，高丽，薛艳，王丽莎，安瑞芳. 经手术治疗宫颈癌患者的临床特征研究[J]. 中国全科医学, 2020, 23(25): 3207-3211.
[12]	黄静，杨湘红，刘爱，周雯娟. 农村地区妇女“两癌筛查”项目实施中的问题与对策[J]. 中国全科医学, 2020, 23(13): 1680-1686.
[13]	余杨，付艳丽，孙翔. 高危型人乳头瘤病毒载量对不同宫颈病变调节性T淋巴细胞表达的影响研究[J]. 中国全科医学, 2019, 22(5): 538-543.
[14]	鲁亮，刘爱华，张汉群，曹辉，李勇，冯志宇，李杭. 培美曲塞联合长春瑞滨治疗一线化疗失败的复发转移性宫颈癌的疗效研究[J]. 中国全科医学, 2019, 22(30): 3679-3682.
[15]	陈文增，陈亚侠. 高危型人乳头瘤病毒阴性宫颈癌患者临床病理特征分析[J]. 中国全科医学, 2019, 22(26): 3179-3183.